Abstract
Although the genetic etiology of ASD is complex, technological and analytical improvements in the field of genetics have enabled researchers to identify genes and genomic regions associated with the risk of developing ASD with higher confidence. As the list of genes, regions, and types of variants associated with ASD risk continues to grow, genetic testing is increasingly available to clinical providers, suggesting that the numbers of individuals diagnosed with ASD who have been screened and tested positive for a molecular genetic diagnosis will continue to grow. Those patients who receive a genetic diagnosis may benefit from treatment recommendations, inclusion in clinical trials, and information on recurrence risks. The objective of this talk is to improve the application of genetic molecular diagnostic testing in clinical mental health practice by reviewing recent genetic studies of ASD, explaining the types of genetic tests clinically available and demonstrating implementation of testing using case examples.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: Journal of the American Academy of Child & Adolescent Psychiatry
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.